Introduction – Company Background

GuangXin Industrial Co., Ltd. is a specialized manufacturer dedicated to the development and production of high-quality insoles.

With a strong foundation in material science and footwear ergonomics, we serve as a trusted partner for global brands seeking reliable insole solutions that combine comfort, functionality, and design.

With years of experience in insole production and OEM/ODM services, GuangXin has successfully supported a wide range of clients across various industries—including sportswear, health & wellness, orthopedic care, and daily footwear.

From initial prototyping to mass production, we provide comprehensive support tailored to each client’s market and application needs.

At GuangXin, we are committed to quality, innovation, and sustainable development. Every insole we produce reflects our dedication to precision craftsmanship, forward-thinking design, and ESG-driven practices.

By integrating eco-friendly materials, clean production processes, and responsible sourcing, we help our partners meet both market demand and environmental goals.

Core Strengths in Insole Manufacturing

At GuangXin Industrial, our core strength lies in our deep expertise and versatility in insole and pillow manufacturing. We specialize in working with a wide range of materials, including PU (polyurethane), natural latex, and advanced graphene composites, to develop insoles and pillows that meet diverse performance, comfort, and health-support needs.

Whether it's cushioning, support, breathability, or antibacterial function, we tailor material selection to the exact requirements of each project-whether for foot wellness or ergonomic sleep products.

We provide end-to-end manufacturing capabilities under one roof—covering every stage from material sourcing and foaming, to precision molding, lamination, cutting, sewing, and strict quality control. This full-process control not only ensures product consistency and durability, but also allows for faster lead times and better customization flexibility.

With our flexible production capacity, we accommodate both small batch custom orders and high-volume mass production with equal efficiency. Whether you're a startup launching your first insole or pillow line, or a global brand scaling up to meet market demand, GuangXin is equipped to deliver reliable OEM/ODM solutions that grow with your business.

Customization & OEM/ODM Flexibility

GuangXin offers exceptional flexibility in customization and OEM/ODM services, empowering our partners to create insole products that truly align with their brand identity and target market. We develop insoles tailored to specific foot shapes, end-user needs, and regional market preferences, ensuring optimal fit and functionality.

Our team supports comprehensive branding solutions, including logo printing, custom packaging, and product integration support for marketing campaigns. Whether you're launching a new product line or upgrading an existing one, we help your vision come to life with attention to detail and consistent brand presentation.

With fast prototyping services and efficient lead times, GuangXin helps reduce your time-to-market and respond quickly to evolving trends or seasonal demands. From concept to final production, we offer agile support that keeps you ahead of the competition.

Quality Assurance & Certifications

Quality is at the heart of everything we do. GuangXin implements a rigorous quality control system at every stage of production—ensuring that each insole meets the highest standards of consistency, comfort, and durability.

We provide a variety of in-house and third-party testing options, including antibacterial performance, odor control, durability testing, and eco-safety verification, to meet the specific needs of our clients and markets.

Our products are fully compliant with international safety and environmental standards, such as REACH, RoHS, and other applicable export regulations. This ensures seamless entry into global markets while supporting your ESG and product safety commitments.

ESG-Oriented Sustainable Production

At GuangXin Industrial, we are committed to integrating ESG (Environmental, Social, and Governance) values into every step of our manufacturing process. We actively pursue eco-conscious practices by utilizing eco-friendly materials and adopting low-carbon production methods to reduce environmental impact.

To support circular economy goals, we offer recycled and upcycled material options, including innovative applications such as recycled glass and repurposed LCD panel glass. These materials are processed using advanced techniques to retain performance while reducing waste—contributing to a more sustainable supply chain.

We also work closely with our partners to support their ESG compliance and sustainability reporting needs, providing documentation, traceability, and material data upon request. Whether you're aiming to meet corporate sustainability targets or align with global green regulations, GuangXin is your trusted manufacturing ally in building a better, greener future.

Let’s Build Your Next Insole Success Together

Looking for a reliable insole manufacturing partner that understands customization, quality, and flexibility? GuangXin Industrial Co., Ltd. specializes in high-performance insole production, offering tailored solutions for brands across the globe. Whether you're launching a new insole collection or expanding your existing product line, we provide OEM/ODM services built around your unique design and performance goals.

From small-batch custom orders to full-scale mass production, our flexible insole manufacturing capabilities adapt to your business needs. With expertise in PU, latex, and graphene insole materials, we turn ideas into functional, comfortable, and market-ready insoles that deliver value.

Contact us today to discuss your next insole project. Let GuangXin help you create custom insoles that stand out, perform better, and reflect your brand’s commitment to comfort, quality, and sustainability.

🔗 Learn more or get in touch:
🌐 Website: https://www.deryou-tw.com/
📧 Email: shela.a9119@msa.hinet.net
📘 Facebook: facebook.com/deryou.tw
📷 Instagram: instagram.com/deryou.tw

Taiwan flexible graphene product manufacturing factory

Are you looking for a trusted and experienced manufacturing partner that can bring your comfort-focused product ideas to life? GuangXin Industrial Co., Ltd. is your ideal OEM/ODM supplier, specializing in insole production, pillow manufacturing, and advanced graphene product design.

With decades of experience in insole OEM/ODM, we provide full-service manufacturing—from PU and latex to cutting-edge graphene-infused insoles—customized to meet your performance, support, and breathability requirements. Our production process is vertically integrated, covering everything from material sourcing and foaming to molding, cutting, and strict quality control.Soft-touch pillow OEM service in Taiwan

Beyond insoles, GuangXin also offers pillow OEM/ODM services with a focus on ergonomic comfort and functional innovation. Whether you need memory foam, latex, or smart material integration for neck and sleep support, we deliver tailor-made solutions that reflect your brand’s values.

We are especially proud to lead the way in ESG-driven insole development. Through the use of recycled materials—such as repurposed LCD glass—and low-carbon production processes, we help our partners meet sustainability goals without compromising product quality. Our ESG insole solutions are designed not only for comfort but also for compliance with global environmental standards.ODM pillow factory in Taiwan

At GuangXin, we don’t just manufacture products—we create long-term value for your brand. Whether you're developing your first product line or scaling up globally, our flexible production capabilities and collaborative approach will help you go further, faster.ODM service for ergonomic pillows Thailand

📩 Contact us today to learn how our insole OEM, pillow ODM, and graphene product design services can elevate your product offering—while aligning with the sustainability expectations of modern consumers.Thailand pillow ODM development service

ARTEMIS, a new machine learning tool by Johns Hopkins researchers, identifies repeat DNA sequences in cancer, enabling noninvasive diagnosis and insights into cancer genetics. It marks a significant advancement in cancer detection and monitoring, with potential applications in early detection and treatment response evaluation. Credit: Carolyn Hruban Identifying and characterizing repeated DNA sequences, sometimes called “junk DNA” or “dark matter” within chromosomes, which may play a role in cancer or other diseases, has proven to be difficult. Now, investigators at the Johns Hopkins Kimmel Cancer Center have developed a novel approach that uses machine learning to identify these elements in cancerous tissue, as well as in cell-free DNA (cfDNA) — fragments that are shed from tumors and float in the bloodstream. This new method could provide a noninvasive means of detecting cancers or monitoring response to therapy. Machine learning is a type of artificial intelligence that uses data and computer algorithms to perform complex tasks and accelerate research. In laboratory tests, the method, called ARTEMIS (Analysis of RepeaT EleMents in dISease) examined over 1,200 types of repeat elements comprising nearly half of the human genome, and identified that a large number of repeats not previously known to be associated with cancer were altered in tumor formation. The investigators also were able to identify changes in these elements in cfDNA, providing a way to detect cancer and determine where in the body it originated. A description of the work is to be published March 13 in Science Translational Medicine. ARTEMIS Unveils the Role of “Dark Genome” in Cancer “When you think about existing cancer genes and the DNA sequences around them, they’re just chock full of these repeats,” says Victor E. Velculescu, M.D., Ph.D., a professor of oncology and co-director of the Cancer Genetics and Epigenetics Program at the Johns Hopkins Kimmel Cancer Center, who led the study with Akshaya Annapragada, an M.D./Ph.D. student at the Johns Hopkins University School of Medicine, and Robert Scharpf, Ph.D., an associate professor of oncology at Johns Hopkins. “Until ARTEMIS, this dark matter of the genome was essentially ignored, but now we’re seeing that these repeats are not occurring randomly,” Velculescu says. “They end up being clustered around genes that are altered in cancer in a variety of different ways, providing the first glimpse that these sequences may be key to tumor development.” In a series of laboratory tests, the researchers first examined the distribution of 1.2 billion kmers (short sequences of DNA) defining unique repeats, finding them enriched in genes commonly altered in human cancers. For example, of 736 genes known to drive cancers, 487 contained an average fifteenfold higher than expected number of repeat sequences. These repeat sequences also were significantly increased in genes involved in cell signaling pathways that are commonly dysregulated in cancers. Using next-generation sequencing, technology that allows researchers to rapidly examine the sequences of entire genomes, the researchers also looked to see if repeat sequences were directly altered in cancers. They used ARTEMIS to analyze over 1,200 distinct types of repeat elements in tumor and normal tissues from 525 patients with different cancers participating in the Pan-Cancer Analysis of Whole Genomes (PCAWG), and found a median of 807 altered elements in each tumor. Nearly two-thirds of these elements (820 of 1,280) had not previously been observed as being altered in human cancers. Then, they used a machine-learning model to generate an ARTEMIS score for each sample to provide a summary of genome-wide repeat element changes that were predictive of cancer. ARTEMIS scores distinguished the 525 PCAWG participants’ tumors from normal tissues with a high performance (AUC=0.96) across all cancer types analyzed, where 1 is a perfect score. Increased ARTEMIS scores were associated with shorter overall and progression-free survival regardless of tumor type. Enhancements in Cancer Detection and Monitoring The investigators next evaluated ARTEMIS’ potential for noninvasive detection of cancer. They applied the tool to blood samples from 287 individuals with and without lung cancer participating in the Danish Lung Cancer Screening Study (LUCAS). ARTEMIS classified patients with lung cancer with an area under the curve (AUC) of 0.82. But when used with another method called DELFI (DNA evaluation of fragments for early interception) — an assay previously developed by Velculescu, Scharpf, and other members of their group that detects changes in the size and distribution of cfDNA fragments across the genome — the combination model classified patients with lung cancer with an AUC of 0.91. Similar performance was observed in a group of 208 individuals at risk for liver cancer, in which ARTEMIS detected individuals with liver cancer among others with cirrhosis or viral hepatitis with an AUC of 0.87. When combined with DELFI, the AUC increased to 0.90. Finally, they evaluated whether the ARTEMIS blood test could identify where in the body a tumor originated in patients with cancer. When trained with information from the PCAWG participants, the tool could classify the source of tumor tissues with an average of 78% accuracy among 12 tumor types. The investigators then combined ARTEMIS and DELFI to assess blood samples from a group of 226 individuals with breast, ovarian, lung, colorectal, bile duct, gastric, or pancreatic tumors. Here, the model correctly classified patients among the different cancer types with an average accuracy of 68%, which improved to 83% when the model was allowed to suggest two possible tumor types instead of a single cancer type. “Our study shows that ARTEMIS can reveal genome-wide repeat landscapes that reflect dramatic underlying changes in human cancers,” Annapragada says. “By illuminating the so-called ‘dark genome,’ the work offers unique insights into the cancer genome and provides a proof-of-concept for the utility of genome-wide repeat landscapes as tissue and blood-based biomarkers for cancer detection, characterization, and monitoring.” Next steps are to evaluate the approach in larger clinical trials, says Velculescu: “You can imagine this could be used for early detection for a variety of cancer types, but also could have uses in other applications such as monitoring response to treatment or detecting recurrence. This is a totally new frontier.” Reference: “Genome-wide repeat landscapes in cancer and cell-free DNA” by Akshaya V. Annapragada, Noushin Niknafs, James R. White, Daniel C. Bruhm, Christopher Cherry, Jamie E. Medina, Vilmos Adleff, Carolyn Hruban, Dimitrios Mathios, Zachariah H. Foda, Jillian Phallen, Robert B. Scharpf and Victor E. Velculescu, 13 March 2024, Science Translational Medicine. DOI: 10.1126/scitranslmed.adj9283 The work was supported in part by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, Stand Up to Cancer (SU2C) in-Time Lung Cancer Interception Dream Team Grant, SU2C-Dutch Cancer Society International Translational Cancer Research Dream Team Grant (SU2C-AACR-DT1415), the Gray Foundation, The Honorable Tina Brozman Foundation, the Commonwealth Foundation, the Mark Foundation for Cancer Research, the Cole Foundation, a research grant from Delfi Diagnostics and U.S. National Institutes of Health grants CA121113, CA006973, CA233259, CA062924, CA271896 and 1T32GM136577. Annapragada, Scharpf, and Velculescu are inventors on patent applications submitted by The Johns Hopkins University related to genome-wide repeat landscapes in cancer and cfDNA. Annapragada, Bruhm, Adleff, Mathios, Foda, Phallen and Scharpf are inventors on patent applications submitted by The Johns Hopkins University related to cell-free DNA for cancer detection that have been licensed to Delfi Diagnostics. White is the founder and owner of Resphera Biosciences LLC and serves as a consultant to Personal Genome Diagnostics Inc. and Delfi Diagnostics Inc. Cherry is the founder and owner of CMCC Consulting. Phallen, Adleff and Scharpf are founders of Delfi Diagnostics, and Adleff and Scharpf are consultants for this organization. Velculescu is a founder of Delfi Diagnostics, serves on the board of directors and owns Delfi Diagnostics stock, which is subject to certain restrictions under university policy. Additionally, The Johns Hopkins University owns equity in Delfi Diagnostics. Velculescu divested his equity in Personal Genome Diagnostics (PGDx) to LabCorp in February 2022. He is an inventor on patent applications submitted by The Johns Hopkins University related to cancer genomic analyses and cell-free DNA for cancer detection that have been licensed to one or more entities, including Delfi Diagnostics, LabCorp, Qiagen, Sysmex, Agios, Genzyme, Esoterix, Ventana and ManaT Bio. Under the terms of these license agreements, the university and inventors are entitled to fees and royalty distributions. Velculescu is also an adviser to Viron Therapeutics and Epitope. These arrangements have been reviewed and approved by The Johns Hopkins University in accordance with its conflict-of-interest policies.

A collage of five of the comb jelly species studied. Red coloration as seen in the two specimens at right is common among deep-sea animals. Credit: Jacob Winnikoff UC San Diego researchers discovered that ctenophores in the deep sea have unique lipid adaptations, called “homeocurvature,” allowing survival in high pressures. These findings might help understand diseases like Alzheimer’s, where similar lipids play a role. The deep sea is one of the most hostile environments on earth. The temperature is freezing cold, there is no light, and the extreme pressure can crush human beings. The animals living at these depths have developed specialized biophysical adaptations to survive these harsh conditions. To investigate these adaptations and how they developed, a team of researchers led by University of California San Diego Assistant Professor of Chemistry and Biochemistry Itay Budin studied the cell membranes of ctenophores, also known as comb jellies. In their study, recently published in Science, they discovered ctenophores have unique lipid structures that allow them to live under intense pressure. Unveiling the Mystery of Lipid Adaptation Although comb jellies resemble jellyfish, they are not closely related. Comprising the phylum Ctenophora, these predators can grow as large as a volleyball and live in oceans around the world at various depths, from the surface down to the deep sea. Cell membranes have thin sheets of lipids and proteins that need to maintain certain properties for cells to function properly. While it has been known for decades that some organisms have adapted their lipids to maintain fluidity in extreme cold — called homeoviscous adaptation — it was unclear how organisms living in the deep sea have adapted to extreme pressure and whether the adaptation to pressure was the same as the adaptation to cold. Budin had been studying homeoviscous adaptation in E. coli bacteria, but when Steven Haddock, senior scientist at the Monterey Bay Aquarium Research Institute (MBARI), asked whether ctenophores had the same homeoviscous adaptation to compensate for extreme pressure, Budin was intrigued. Complex organisms have different types of lipids. Humans have thousands of them: the heart has different ones than the lungs, which are different from those in the skin, and so on. They have different shapes too: some are cylindrical and some are shaped like cones. SCUBA diving for shallow-water comb jellies off the Big Island of Hawaii. Most comb jellies live in the open ocean, where divers have to use tethers to avoid drifting away. Credit: Jacob Winnikoff Discovery of Homeocurvature in Ctenophores To answer whether ctenophores adapted to cold and pressure through the same mechanism, the team needed to control the temperature variable. Jacob Winnikoff, the study’s lead author who worked at both MBARI and UC San Diego, analyzed ctenophores collected from across the northern hemisphere, including those that lived at the bottom of the ocean in California (cold, high pressure) and those from the surface of the Arctic Ocean (cold, lower pressure). “It turns out that ctenophores have developed unique lipid structures to compensate for the intense pressure that are separate from the ones that compensate for intense cold,” stated Budin. “So much so that the pressure is actually what’s holding their cell membranes together.” The researchers call this adaptation “homeocurvature” because the curve-forming shape of the lipids has adapted to the ctenophores’ unique habitat. In the deep sea, the cone-shaped lipids have evolved into exaggerated cone shapes. The pressure of the ocean counteracts the exaggeration so the lipid shape is normal, but only at these extreme pressures. When deep-sea ctenophores are brought up to the surface, the exaggerated cone shape returns, the membranes split apart, and the animals disintegrate. Potential Medical Implications of Deep-Sea Research The molecules with an exaggerated cone shape are a type of phospholipid called plasmalogens. Plasmalogens are abundant in human brains and their declining abundance often accompanies diminishing brain function and even neurodegenerative diseases like Alzheimer’s. This makes them very interesting to scientists and medical researchers. “One of the reasons we chose to study ctenophores is because their lipid metabolism is similar to humans,” stated Budin. “And while I wasn’t surprised to find plasmalogens, I was shocked to see that they make up as much as three-quarters of a deep-sea ctenophore’s lipid count.” To further test this discovery, the team went back to E. coli, conducting two experiments in high-pressure chambers: one with unaltered bacteria and a second with bacteria that had been bioengineered to synthesize plasmalogens. While the unaltered E. coli died off, the E. coli strain containing plasmalogens thrived. Collaborative Efforts and Future Directions These experiments were conducted over several years and with collaborators across multiple institutions and disciplines. At UC San Diego, in addition to Budin, whose group conducted the biophysics and microbiology experiments, Distinguished Professor of Chemistry and Biochemistry Edward Dennis’s lab conducted lipid analysis by mass spectrometry. Marine biologists at MBARI collected ctenophores to study, while physicists at the University of Delaware ran computer simulations to validate membrane behaviors at different pressures. Budin, who is interested in studying how cells regulate lipid production, hopes this discovery will lead to further investigations into the role plasmalogens play in brain health and disease. “I think the research shows that plasmalogens have really unique biophysical properties,” he said. “So now the question is, how are those properties important for the function of our own cells? I think that’s one takeaway message.” Reference: “Homeocurvature adaptation of phospholipids to pressure in deep-sea invertebrates” by Jacob R. Winnikoff, Daniel Milshteyn, Sasiri J. Vargas-Urbano, Miguel A. Pedraza-Joya, Aaron M. Armando, Oswald Quehenberger, Alexander Sodt, Richard E. Gillilan, Edward A. Dennis, Edward Lyman, Steven H. D. Haddock and Itay Budin, 27 June 2024, Science. DOI: 10.1126/science.adm7607 Funding: This research was supported through grants by the National Science Foundation, the National Aeronautics and Space Administration, the National Institutes of Health, the Office of Naval Research, and the David and Lucile Packard Foundation.

Chucao Tapaculo. Humans like truffles, as do many mammals. Now new evidence suggests that birds may also seek out and disperse these ecologically important fungi. A study conducted by University of Florida researchers found that two common ground-dwelling bird species in Patagonia regularly consume truffles and pass on viable truffle spores through their feces. “Truffles are essentially mushrooms that grow underground. Unlike aboveground mushrooms, which release their spores into the air, truffles depend on animals consuming them to spread their spores,” said Matthew E. Smith, senior author on the study and an associate professor in the UF/IFAS plant pathology department. “Previously, it was assumed that only mammals consumed and dispersed truffle spores, so our study is the first to document birds doing this as well,” said Marcos Caiafa, first author of the study, who recently received a doctorate in plant pathology from the UF/IFAS College of Agricultural and Life Sciences. Smith was Caiafa’s dissertation adviser. The term “truffle” includes hundreds of species of underground fungi, only a few of which are the truffles people associate with high-end cuisine. While non-culinary truffles may not appeal to human foodies, each has evolved to attract different animals that can assist in its spread. The spreading of truffle spores is an important part of a healthy forest ecosystem, Smith said, as many tree species have a symbiotic relationship with truffles, which colonize the roots of the trees. “These fungi form mycorrhizas, a relationship whereby the fungus helps the plant take up nutrients in exchange for sugars from the plant,” explained Caiafa, who is now a postdoctoral researcher at the University of California, Riverside.   The bird species they studied — chucao tapaculos and black-throated huet-huets — not only eat truffles but appear to search them out specifically. In the past these birds were known to eat invertebrates, seeds and fruits, but their consumption of fungi was not previously documented, the researchers said. “The questions about birds and truffles emerged during an earlier research project in Patagonia. We are working in the forest, raking the soil and digging up the truffles, and we notice these birds keep following us around and checking out the areas where we had disturbed the soil. Then we find truffles with chunks pecked out of them. Marcos even saw a bird eat a truffle right in front of him. All of this led us to ask, are these birds hunting for truffles?” Smith said. To confirm this hypothesis, the research team collected the droppings of chucao tapaculos and black-throated huet-huets and tested them for truffle DNA. They found truffle DNA in 42% of chucao tupaculo and 38% of huet-huet feces. They also used a special microscope technique, fluorescent microscopy, to confirm that the spores in the feces were viable, suggesting that the birds are spreading truffles to new areas.  “DNA-based diet analysis is exciting because it provides new insights into interactions between organisms that would otherwise be difficult to directly observe,” said Michelle Jusino, one of the study’s co-authors and a former postdoctoral researcher in Smith’s lab.   “And, because sampling feces does not negatively impact the target species, I think these methods are invaluable for studying and protecting both common and rare species in the future,” said Jusino, who is now a research biologist with the U.S. Forest Service Northern Research Station’s Center for Forest Mycology Research. The study’s authors think that some truffles in Patagonia may have evolved to attract birds. “Some of truffles that the birds eat are brightly colored and resemble local berries. Our future research may look to see if there is an evolutionary adaptation there — that the truffles have evolved to look more like the berries that the birds also eat,” Smith said. Reference: “Discovering the role of Patagonian birds in the dispersal of truffles and other mycorrhizal fungi” by Marcos V. Caiafa, Michelle A. Jusino, Ann C. Wilkie, Iván A. Díaz, Kathryn E. Sieving and Matthew E. Smith, 28 October 2021, Current Biology. DOI: 10.1016/j.cub.2021.10.024 The study was supported by a National Geographic Explorer Grant and a grant from the National Science Foundation. The paper is published in the journal Current Biology.

DVDV1551RTWW78V